Quercetin is a flavonoid found in onions, apples and tea, and Japanese manufacturers have built a body of work around a specific form of it — enzymatically modified isoquercitrin — because the plain aglycone absorbs poorly. Brands abroad ask for a Japan-made quercetin product on the strength of that formulation know-how.
The form matters more than the name on the label. This guide separates what is known about absorption from what human trials actually show for body fat, and what that means for a Japan-made specification.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a quercetin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
Why the glycoside form matters
Quercetin joined to a glucose molecule is absorbed faster and reaches far higher blood levels than the same amount joined to rutinose, the sugar in rutin.
| Study | What was compared | Reported result |
|---|---|---|
| Crossover pharmacokinetic study, Journal of Clinical Pharmacology 2001 (PMID 11361045) | Quercetin-4’-O-glucoside (from an onion supplement) versus quercetin-3-O-rutinoside (rutin), 12 healthy adults | Peak plasma quercetin was about 2.3 µg/mL at 0.7 hours after the glucoside, versus about 0.3 µg/mL at 7.0 hours after rutin; the authors concluded that the sugar moiety, not the dose, chiefly determines how quercetin is absorbed |
| Narrative review, International Journal of Molecular Sciences 2022 (PMID 36499113) | Production, metabolism and pharmacology of enzymatically modified isoquercitrin (EMIQ), a mixture of quercetin glucosides made from rutin by enzymatic conversion | Enzymatic conversion to glucoside forms substantially increases bioavailability compared with the starting rutin, addressing the poor water solubility and absorption that limit plain quercetin |
Two forms therefore turn up in ingredient lists with very different absorption profiles: quercetin aglycone or rutin (poorly absorbed, slowly), and quercetin glucosides such as EMIQ (absorbed faster, to higher blood levels). Human trial results for one do not describe the other, and a product specification should say which form is used, not just “quercetin”.
Checked against the published abstracts on 25 September 2026.
What the human body-fat trials show
The clearest randomised human trial of a quercetin glucoside on body composition, run in Japanese athletes, found no significant difference in body weight, fat mass or lean body mass.
| Study | Design | Reported result |
|---|---|---|
| Randomised, placebo-controlled, double-blind trial, Journal of the International Society of Sports Nutrition 2019 (PMID 31500646) | 39 Japanese male American football players, EMIQ added to whey protein versus whey protein alone, 4 months | No significant differences in body mass, lean body mass, fat mass or lower limb fat mass between groups; the EMIQ group did show a significantly greater increase in lower limb muscle mass |
This is a trial in young, physically active men doing structured training, not a general weight-management population, and it did not report a body-fat benefit. Marketing that cites “Japanese research on quercetin and body fat” without naming which trial, and in which population, risks overstating this evidence. Separate industry-funded studies in adults with a higher body-mass index have reported reductions in abdominal fat area with quercetin glucoside beverages, but the details of dose, funding and population vary between them, and this guide only cites the trial verified above.
What Japanese products say
Quercetin glycosides are notified under Japan’s Foods with Function Claims system for functions related to visceral fat, triglycerides and other body-fat markers, based on evidence the notifying business submits.
Under this system, the Consumer Affairs Agency receives the notification and supporting evidence before sale; it does not independently re-test the claim. Notified wording for quercetin glycoside products describes everyday, measurable states — visceral fat area, body fat percentage — not disease outcomes, and the specific evidence behind each notification varies by product.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent trial data? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe the glycoside form and what has actually been studied, not a general “burns fat” claim.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains quercetin glucoside (enzymatically modified isoquercitrin)” with the amount | ”Quercetin” alone, when the form is really rutin or aglycone |
| ”Studied for body fat area in adults” (citing the specific population studied) | “Burns fat” or “melts belly fat" |
| "Absorbed more readily than quercetin aglycone” | Disease names, or “treats” obesity or metabolic syndrome |
How quercetin is formulated
Quercetin glucosides are water-soluble and stable enough for drinks and confectionery, while the plain aglycone needs a delivery approach to be usable at all.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Drink or beverage powder | Matches the form used in the Japanese trials, familiar format | Taste and colour stability |
| Tablet or hard capsule | Simple, precise dosing | Aglycone forms may need a solubility-enhancing approach |
| Confectionery | Everyday consumption format | Sugar content and your market’s rules on supplement-like foods |
Decisions that shape the specification:
- Glycoside form. Specify quercetin glucoside (EMIQ-type) or aglycone; they are not interchangeable, and neither is the evidence behind them.
- Amount per serving. Match it to the population and trial you intend to reference, and be able to show the source.
- Source material. Quercetin glucosides used in Japan are typically made by enzymatic conversion of rutin extracted from plant sources such as sophora (pagoda tree) buds; ask the supplier for the conversion method and glucoside purity.
- Companion ingredients. Weight-management formulas often combine quercetin with other actives. Each ingredient needs its own check against Japanese food law.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Quercetin glucosides used in foods are established in Japan. The risk usually sits in companion actives in weight-management formulas, some of which are treated as medicines in Japan even where they are sold freely as foods elsewhere. See the Japan-made supplement OEM page, and compare with our hesperidin and green tea catechin guides for two other flavonoids with their own evidence profile.
Before you ask for a quotation
A factory can quote accurately once the glycoside form, the amount, the companions and the packaging are fixed.
- Quercetin form (glucoside/EMIQ-type or aglycone) and the amount per serving
- Source and conversion method
- Dosage form and flavour
- Companion ingredients and their amounts
- Countries you will sell in
- First order and annual volume
💬 Ready to design a Japan-made quercetin product? Send us the concept — glycoside form, amount, dosage form and the countries you will sell in.
Frequently asked questions
1. Is quercetin the same as quercetin glucoside?
No. Plain quercetin (the aglycone) and rutin absorb slowly and to low blood levels compared with quercetin glucosides such as enzymatically modified isoquercitrin. A 2001 pharmacokinetic study found peak plasma levels roughly seven-fold higher, and reached far sooner, after a glucoside than after rutin.
2. Does Japanese research show quercetin reduces body fat?
The verified randomised trial in Japanese athletes found no significant difference in fat mass after four months of a quercetin glucoside added to protein powder, though it did find a greater increase in lower-limb muscle mass. Describe quercetin glucoside as studied for body composition, not as a proven fat-loss ingredient.
3. Why do Japanese products list quercetin glycoside for visceral fat?
Japan’s Foods with Function Claims system lets a notifying business present its own evidence for a stated function, including visceral fat area, and submit it to the Consumer Affairs Agency before sale. That is a Japanese regulatory mechanism, and the evidence behind each notification varies by product.
4. Which dosage form suits quercetin glucoside best?
Drinks and beverage powders are common because that is the form used in the trials, and because the glucoside form is water-soluble. Tablets and capsules also work well.
5. What can stop a Japanese factory making my quercetin product?
Usually a companion active in a weight-management formula that Japan treats as a medicine rather than a food ingredient. Every ingredient must be permitted in foods in Japan, so we check the full formula first.
Sources: “Pharmacokinetics and bioavailability of quercetin glycosides in humans”, Journal of Clinical Pharmacology 2001 (PMID 11361045); “Enzymatically Modified Isoquercitrin: Production, Metabolism, Bioavailability, Toxicity, Pharmacology, and Related Molecular Mechanisms”, International Journal of Molecular Sciences 2022 (PMID 36499113); “Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial”, Journal of the International Society of Sports Nutrition 2019 (PMID 31500646); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.